Menu
Zhejiang Honor Biotechnology Co., Ltd.
Email: zhaoqiang.peng@rongyaobiotech.com
Address: No. 30, Duchuan South Road, Linhai Industrial Park, Zhejiang Province Chemical API Base
NEWS
RONGYAO BIOTECH
What is the manufacturing process for pharmaceutical starting materials?
Release time: 2026/03/30
The manufacturing process for a starting material typically refers to the synthesis or preparation of the chemical entity itself, which must exhibit reproducibility, quality control, and the capacity for commercial-scale supply—making it a critical preliminary step in the overall process development of an active pharmaceutical ingredient. According to ICH Q11 guidelines, a starting material should not be a simple commercially available reagent; rather, it must have a well-defined structure and a key functional role, and its production often involves multi-step organic synthesis or specialized extraction processes.
Common types of starting material manufacturing processes include:
Total Chemical Synthesis Process
The target molecular scaffold is constructed from basic chemical feedstocks through multi-step organic reactions, such as substitution, addition, coupling, and reduction. For example, the starting material for a certain antiviral drug is a fluorinated aromatic amine, and its synthetic route comprises three sequential steps—nitration, fluorination, and reduction—each of which requires stringent control over byproduct formation and the generation of isomers.
Chiral Synthesis or Resolution Techniques
For starting materials containing chiral centers, asymmetric catalytic synthesis (e.g., using chiral catalysts) or resolution of racemates (e.g., crystallization or enzymatic methods) are commonly employed to obtain products with high optical purity, thereby ensuring stereochemical consistency of the subsequent API.
Combination of natural extraction and semi-synthesis
Certain complex-structured starting materials are derived from natural resources; for example, 6-APA (6-aminopenicillanic acid) is extracted from penicillin G fermentation broth and serves as a common precursor for β-lactam antibiotics, while diosgenin is extracted from plants for the synthesis of steroid hormone drug precursors.
Solid-phase synthesis (for nucleoside starting materials)
In the research and development of oligonucleotide therapeutics, nucleoside phosphoramidite monomers are commonly used as starting materials and are sequentially assembled on a resin support via solid-phase synthesis, offering advantages of high purity and sequence control.
Custom Contract Manufacturing (CMO/CDMO Model)
Most starting materials are custom-manufactured by specialized suppliers in accordance with customer requirements, and require the submission of a complete process route, impurity profile analysis, quality specifications, and GMP audit reports to ensure supply chain stability and compliance.
The entire manufacturing process must be supported by a comprehensive quality control system, encompassing traceability of raw material origins, monitoring of critical intermediates, structural confirmation of the final product (e.g., via NMR, HPLC, and MS), and establishment of impurity limits, thereby underpinning the scientific rationale and regulatory compliance of the process as a “process starting point.”
Glory
Zhejiang Honor Biotechnology Co., Ltd.
No. 30, Duchuan South Road, Linhai Industrial Park, Zhejiang Province Chemical API Base